Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
J Interv Card Electrophysiol ; 66(8): 1889-1899, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-36807734

RESUMEN

BACKGROUND: Electrical isolation of pulmonary veins (PV) with high-power short-duration (HPSD) radiofrequency application (RFa) may reduce the duration of atrial fibrillation (AF) ablation, without compromising the procedural efficacy and safety in comparison with the conventional approach. This hypothesis has been generated in several observational studies; the POWER FAST III will test it in a randomized multicenter clinical trial. METHODS: It is a multicenter randomized, open-label and non-inferiority clinical trial with two parallel groups. AF ablation using 70 W and 9-10 s RFa is compared with the conventional technique using 25-40 W RFa guided by numerical lesion indexes. The main efficacy objective is the incidence of atrial arrhythmia recurrences electrocardiographically documented during 1-year follow-up. The main safety objective is the incidence of endoscopically detected esophageal thermal lesions (EDEL). This trial includes a substudy of incidence of asymptomatic cerebral lesions detected by magnetic resonance imaging (MRI) after ablation. RESULTS: A randomized clinical trial compares for the first time high-power short-duration and conventional ablation in order to obtain data about the efficacy and safety of the high-power technique in an adequate methodological context. CONCLUSIONS: The results of the POWER FAST III could support the use of the high-power short-duration ablation in clinical practice. REGISTRATION: ClinicalTrials.gov: NTC04153747.

6.
Rev. colomb. anestesiol ; 46(4): 341-344, 2018.
Artículo en Inglés | LILACS, COLNAL | ID: biblio-978218

RESUMEN

Abstract A case of intraoperative awareness during ablation of pulmonary veins-one of the most widely used techniques in interventional cardiology-is discussed. An infusion of isoproterenol was administered following the ablation of ectopic foci. A few seconds after the infusion the patient experienced increased heart rate and intraoperative awareness manifested as an abrupt patient movement and bispectral index elevation. This has been described in similar procedures, following the administration of isoproterenol. In our opinion, the isoproterenol infusion caused the increased heart rate and subsequent abrupt rise in cardiac output. As an inversely proportional relationship between the propofol concentrations and cardiac output has been described, we believe that this rise in cardiac output could have favored the decline in the concentrations of propofol, leading to an intraoperative awareness episode.


Resumen Presentamos un caso de despertar intraoperatorio durante la ablación de venas pulmonares, una de las técnicas más empleadas por los cardiólogos intervencionistas. Tras la ablación de focos ectópicos se procede a la infusión de isoproterenol. Segundos después de la infusión se produce un aumento de la frecuencia cardíaca seguido de un despertar intraoperatorio traducido como un movimiento brusco del paciente y un aumento en el índice bi-espectral (BIS). Esto ha sido descrito en procedimientos similares tras la administración de isoproterenol. En nuestra opinión, la infusión de isoproterenol provocó un aumento de la frecuencia cardiaca y secundariamente del gasto cardíaco de forma brusca. Dado que se ha descrito una relación inversamente propocional entre las concentraciones de propofol y el gasto cardíaco, pensamos que este aumento del gasto cardíaco pudo condicionar un descenso de las concentraciones de propofol y esto causar el episodio de despertar intraoperatorio.


Asunto(s)
Humanos , Persona de Mediana Edad , Venas Pulmonares , Gasto Cardíaco , Propofol , Ablación por Catéter , Despertar Intraoperatorio , Isoproterenol , Anestésicos , Cardiología , Ruscus , Cardiólogos , Frecuencia Cardíaca
7.
J Am Coll Cardiol ; 68(22): 2440-2451, 2016 Dec 06.
Artículo en Inglés | MEDLINE | ID: mdl-27908349

RESUMEN

BACKGROUND: Filamin C (encoded by the FLNC gene) is essential for sarcomere attachment to the plasmatic membrane. FLNC mutations have been associated with myofibrillar myopathies, and cardiac involvement has been reported in some carriers. Accordingly, since 2012, the authors have included FLNC in the genetic screening of patients with inherited cardiomyopathies and sudden death. OBJECTIVES: The aim of this study was to demonstrate the association between truncating mutations in FLNC and the development of high-risk dilated and arrhythmogenic cardiomyopathies. METHODS: FLNC was studied using next-generation sequencing in 2,877 patients with inherited cardiovascular diseases. A characteristic phenotype was identified in probands with truncating mutations in FLNC. Clinical and genetic evaluation of 28 affected families was performed. Localization of filamin C in cardiac tissue was analyzed in patients with truncating FLNC mutations using immunohistochemistry. RESULTS: Twenty-three truncating mutations were identified in 28 probands previously diagnosed with dilated, arrhythmogenic, or restrictive cardiomyopathies. Truncating FLNC mutations were absent in patients with other phenotypes, including 1,078 patients with hypertrophic cardiomyopathy. Fifty-four mutation carriers were identified among 121 screened relatives. The phenotype consisted of left ventricular dilation (68%), systolic dysfunction (46%), and myocardial fibrosis (67%); inferolateral negative T waves and low QRS voltages on electrocardiography (33%); ventricular arrhythmias (82%); and frequent sudden cardiac death (40 cases in 21 of 28 families). Clinical skeletal myopathy was not observed. Penetrance was >97% in carriers older than 40 years. Truncating mutations in FLNC cosegregated with this phenotype with a dominant inheritance pattern (combined logarithm of the odds score: 9.5). Immunohistochemical staining of myocardial tissue showed no abnormal filamin C aggregates in patients with truncating FLNC mutations. CONCLUSIONS: Truncating mutations in FLNC caused an overlapping phenotype of dilated and left-dominant arrhythmogenic cardiomyopathies complicated by frequent premature sudden death. Prompt implantation of a cardiac defibrillator should be considered in affected patients harboring truncating mutations in FLNC.


Asunto(s)
Cardiomiopatías/genética , ADN/genética , Filaminas/genética , Mutación , Taquicardia Ventricular/genética , Adolescente , Adulto , Anciano , Cardiomiopatías/etiología , Cardiomiopatías/metabolismo , Niño , Preescolar , Análisis Mutacional de ADN , Femenino , Filaminas/metabolismo , Genotipo , Humanos , Inmunohistoquímica , Lactante , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Factores de Riesgo , Taquicardia Ventricular/complicaciones , Taquicardia Ventricular/metabolismo , Adulto Joven
8.
Eur Heart J Acute Cardiovasc Care ; 5(7): 41-50, 2016 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26589727

RESUMEN

BACKGROUND: Aspirin hypersensitivity is not a rare condition among patients with acute coronary syndrome. However, despite the publication of several successful desensitization protocols, the procedure is not as widespread as expected. We present a cohort of patients with acute coronary syndrome undergoing aspirin desensitization to evaluate its short- and long-term efficacy and safety and to reinforce data from previous studies. METHODS: Of 1306 patients admitted to our Coronary Care Unit between February 2011 and February 2013, 24 (1.8%) had a history of aspirin hypersensitivity. All 24 patients underwent an eight-dose aspirin desensitization protocol (0.1, 0.3, 1, 3, 10, 25, 50 and 100 mg of aspirin given by mouth every 15 minutes) after premedication with antihistamines and corticosteroids or antileucotrienes. Previously prescribed ß blockers and angiotensin-converting enzyme inhibitors were not discontinued. All patients were desensitized within 72 hours of admission. Those requiring urgent catheterization (five patients with ST segment elevation myocardial infarction) were desensitized within 12 hours of catheterization and the remainder before catheterization. RESULTS: All patients were successfully desensitized and only one presented with an urticarial reaction. The five patients with ST segment elevation myocardial infarction were treated with abciximab until desensitization was complete. All but one patient underwent catheterization and 20 underwent percutaneous coronary intervention, most (66%) with the implantation of a bare metal stent. At follow-up (a minimum of 6-24 months), only two patients had discontinued aspirin, both due to gastrointestinal bleeding, and no hypersensitivy reaction had occurred. CONCLUSIONS: Aspirin desensitization is effective and safe in unstable patients with acute coronary syndrome in both the short and long term.


Asunto(s)
Síndrome Coronario Agudo/tratamiento farmacológico , Aspirina/administración & dosificación , Aspirina/efectos adversos , Desensibilización Inmunológica/métodos , Hipersensibilidad a las Drogas/prevención & control , Síndrome Coronario Agudo/cirugía , Anciano , Anciano de 80 o más Años , Cateterismo Cardíaco , Desensibilización Inmunológica/efectos adversos , Hipersensibilidad a las Drogas/etiología , Hipersensibilidad a las Drogas/inmunología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Intervención Coronaria Percutánea , Estudios Prospectivos , Resultado del Tratamiento
9.
Arch Cardiol Mex ; 84(1): 10-6, 2014.
Artículo en Español | MEDLINE | ID: mdl-24656925

RESUMEN

OBJECTIVE: To compare the prognosis during hospitalization and maximum follow-up of 4 years in patients with myocardial infarction complicated with cardiogenic shock. METHOD: Prospective observational study practiced in a coronary Care Unit managed by cardiologists. We included patients with myocardial infarction complicated with cardiogenic shock who received early coronary revascularization. Patients were divided into two groups: older than 75 years (group A) and lower (group B), and we compared the evolution during hospitalization and maximum follow-up of 4 years. Primary end point was mortality rate in the maximum follow-up of 4years. Secondary end point was mortality rate during hospitalization. RESULTS: Ninety-seven patients were included, 45% Group A. Patients of Group B were mostly men (81% vs. 57%; P=.014), diabetics (48% vs. 21%; P=0.006), and smokers (39.6% vs. 5%). Mortality rate during hospitalization was higher in Group A (54.5%) vs. 30.2% in Group B (P=.022). Mortality rate during follow-up (primary variable) was 73% in Group A vs. 38% in Group B (P=.007). CONCLUSIONS: Myocardial infarction complicated with cardiogenic shock in elderly patients is an entity with high mortality during hospitalization and continues to worsen during long term follow-up.


Asunto(s)
Isquemia Miocárdica/mortalidad , Choque Cardiogénico/mortalidad , Factores de Edad , Anciano , Femenino , Humanos , Masculino , Isquemia Miocárdica/complicaciones , Pronóstico , Estudios Prospectivos , Choque Cardiogénico/etiología , Tasa de Supervivencia , Factores de Tiempo
10.
Arch. cardiol. Méx ; 84(1): 10-16, ene.-mar. 2014. ilus, tab
Artículo en Español | LILACS | ID: lil-712905

RESUMEN

Objetivo: Comparar la evolución durante el ingreso y a largo plazo de pacientes con choque cardiogénico de origen isquémico. Método: Estudio observacional prospectivo unicéntrico llevado a cabo en la unidad coronaria de un hospital terciario manejada por cardiólogos. Se incluyen pacientes con choque cardiogénico de origen isquémico que recibieron revascularización coronaria precoz. Dividimos a los pacientes en 2 grupos: mayores de 75 anos (grupo A) y menores (grupo B), y comparamos la evolución durante el ingreso y en un seguimiento máximo de 4 años. El objetivo principal fue estimar la mortalidad a los 4 años. El objetivo secundario se definió como la mortalidad intrahospitalaria. Resultados: Incluimos a 97 pacientes, 44 del grupo A (45%). Los pacientes del grupo B eran con más frecuencia varones (81 vs. 57%, p = 0.014), diabéticos (49 vs. 21%, p: 0.006) y fumadores (39.6 vs. 4.5%, p < 0.05). La mortalidad hospitalaria fue superior en el grupo A (54.5 vs. 30.2%, p = 0.022). El objetivo principal ocurrió en 32 pacientes del grupo A frente a 20 del grupo B (73 vs. 38%, p = 0.007). Conclusión: El choque cardiogénico de origen isquémico en paciente mayores de 75 anos presenta una alta mortalidad durante la estancia hospitalaria y en el seguimiento a largo plazo.


Objective: To compare the prognosis during hospitalization and maximum follow-up of 4 years in patients with myocardial infarction complicated with cardiogenic shock. Method: Prospective observational study practiced in a coronary Care Unit managed by cardiologists. We included patients with myocardial infarction complicated with cardiogenic shock who received early coronary revascularization. Patients were divided into two groups: older than 75 years (group A) and lower (group B), and we compared the evolution during hospitalization and maximum follow-up of 4 years. Primary end point was mortality rate in the maximum follow-up of 4years. Secondary end point was mortality rate during hospitalization. Results: Ninety-seven patients were included, 45% Group A. Patients of Group B were mostly men (81% vs. 57%; P =.014), diabetics (48% vs. 21%; P = 0.006), and smokers (39.6% vs. 5%). Mortality rate during hospitalization was higher in Group A (54.5%) vs. 30.2% in Group B(P = .022). Mortality rate during follow-up (primary variable) was 73% in Group A vs. 38% in Group B (P =.007). Conclusions: Myocardial infarction complicated with cardiogenic shock in elderly patients is an entity with high mortality during hospitalization and continues to worsen during long term follow-up.


Asunto(s)
Anciano , Femenino , Humanos , Masculino , Isquemia Miocárdica/mortalidad , Choque Cardiogénico/mortalidad , Factores de Edad , Isquemia Miocárdica/complicaciones , Pronóstico , Estudios Prospectivos , Tasa de Supervivencia , Choque Cardiogénico/etiología , Factores de Tiempo
13.
Rev. argent. cardiol ; 80(3): 250-252, jun. 2012. ilus
Artículo en Español | LILACS | ID: lil-657567

RESUMEN

Esporádicamente se presentan en la práctica clínica casos de heridas por arma de fuego que afectan el corazón, el pericardio y los grandes vasos. En el caso concreto de España, la afición a la caza hace que se atiendan pacientes con impacto de perdigones por accidente. El tratamiento de este tipo de traumatismo no está estandarizado, debido fundamentalmente a los pocos afectados tratados en cada centro particular. En esta presentación se describen dos casos consecutivos atendidos en nuestra institución por impacto de perdigón sobre estructuras cardíacas y cuya evolución fue satisfactoria con tratamiento conservador.


Cardiac shotgun injuries affecting the heart, pericardium and great vessels are occasionally encountered in clinical practice. Specifically in Spain, pellet wounds from hunting accidents have increased. The treatment of these injuries is not standardized due to the small number of cases attended in each particular center. We present two consecutive cases of cardiac pellet-gun related injuries treated in our institution with a conservative approach, with favorable outcomes.

14.
Rev. argent. cardiol ; 80(3): 250-252, jun. 2012. ilus
Artículo en Español | BINACIS | ID: bin-129271

RESUMEN

Esporádicamente se presentan en la práctica clínica casos de heridas por arma de fuego que afectan el corazón, el pericardio y los grandes vasos. En el caso concreto de España, la afición a la caza hace que se atiendan pacientes con impacto de perdigones por accidente. El tratamiento de este tipo de traumatismo no está estandarizado, debido fundamentalmente a los pocos afectados tratados en cada centro particular. En esta presentación se describen dos casos consecutivos atendidos en nuestra institución por impacto de perdigón sobre estructuras cardíacas y cuya evolución fue satisfactoria con tratamiento conservador.(AU)


Cardiac shotgun injuries affecting the heart, pericardium and great vessels are occasionally encountered in clinical practice. Specifically in Spain, pellet wounds from hunting accidents have increased. The treatment of these injuries is not standardized due to the small number of cases attended in each particular center. We present two consecutive cases of cardiac pellet-gun related injuries treated in our institution with a conservative approach, with favorable outcomes.(AU)

15.
Rev. clín. med. fam ; 4(3): 259-263, oct. 2011. tab, ilus
Artículo en Español | IBECS | ID: ibc-93609

RESUMEN

Presentamos el caso de una mujer de 79 años que ingresa en el servicio de Cardiología tras acudir a Urgencias con síntomas sugerentes de un síndrome coronario agudo, llegando a un diagnóstico cada vez más frecuente y quizá infradiagnosticado años atrás. El Síndrome de Takotsubo es una entidad clínica predominante en mujeres postmenopáusicas y se presenta típicamente tras un estrés físico o psíquico intenso. El cuadro clínico remeda el de un síndrome coronario agudo, sin embargo es característica la ausencia de lesiones angiográficas coronarias y un patrón ecocardiográfico de "balonización" del ventrículo izquierdo por hipercontractilidad de los segmentos basales y discinesia apical. Estas alteraciones suelen recuperarse completamente en el transcurso de unas semanas. Exponemos además una pequeña revisión sobre el estado actual del diagnóstico y tratamiento (AU)


We report a case of a 79 year old woman admitted to our Cardiology department for symptoms suggestive of acute coronary syndrome, eventually reaching an increasingly common diagnosis of a syndrome that was perhaps under-diagnosed in previous years. Takotsubo syndrome is a clinical entity predominantly occurring in postmenopausal women typically after severe physical or psychological stress. The symptoms mimic an acute coronary syndrome, however the absence of coronary angiographic lesions and an echocardiographic pattern of "apical ballooning" in the left ventricle because of hyperkinesis of the basal segments and apical dyskinesia are characteristic of this syndrome. These symptoms are usually fully resolved within a few weeks. We also present a brief review of the current state of its diagnosis and treatment (AU)


Asunto(s)
Humanos , Femenino , Persona de Mediana Edad , Dolor en el Pecho/complicaciones , Dolor en el Pecho/diagnóstico , Infarto del Miocardio/complicaciones , Infarto del Miocardio/diagnóstico , Cardiomiopatía de Takotsubo/complicaciones , Cardiomiopatía de Takotsubo/diagnóstico , Síndrome de QT Prolongado/complicaciones , Electrocardiografía , Dolor en el Pecho/fisiopatología , Dolor en el Pecho/terapia , Cardiomiopatía de Takotsubo/patología , Cardiomiopatía de Takotsubo , Ecocardiografía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA